Interestingly, Ogawa et al.[39] demonstrated that orally administered L. casei was effective in the control of the IgE levels in human allergic reactions and, recently, Schiffer et al.[40] reported that L. casei could inhibit the effector phase of immune inflammation in vivo. This evidence concerns the gene IGHE and allergic disease.